Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1984-11-9
|
pubmed:abstractText |
Whether central histaminergic (HAergic) neurons mediate the regulation of methamphetamine (MAMP)-induced hyperactivity was clarified. L-histidine (HIS; 500 and 1000 mg/kg i.p.) reduced the locomotor hyperactivity induced by MAMP (1 mg/kg i.p.) in mice, and the effect was significant only at 1000 mg/kg. HIS significantly elevated brain histamine (HA) levels, in both doses, whereas telemethylhistamine (t-MH) levels were elevated only at 1000 mg/kg. Pretreatment with alpha-fluoromethylhistidine, a histidine decarboxylase inhibitor, suppressed both behavioral and biochemical effects of HIS. Metoprine, a HA-N-methyltransferase inhibitor, increased brain HA levels, decreased t-MH levels and suppressed the MAMP-induced locomotor hyperactivity. It is concluded that central HAergic systems may play an inhibitory role on the MAMP-induced locomotor hyperactivity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0304-3940
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
305-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6541326-Animals,
pubmed-meshheading:6541326-Histamine,
pubmed-meshheading:6541326-Humans,
pubmed-meshheading:6541326-Hyperkinesis,
pubmed-meshheading:6541326-Male,
pubmed-meshheading:6541326-Methamphetamine,
pubmed-meshheading:6541326-Mice,
pubmed-meshheading:6541326-Mice, Inbred Strains,
pubmed-meshheading:6541326-Motor Activity,
pubmed-meshheading:6541326-Neurons
|
pubmed:year |
1984
|
pubmed:articleTitle |
Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|